#PortfolioNews | Adcendo receives #FDA clearance for Phase I trial of ADCE-T02

🎯 First-in-class #ADC targeting Tissue Factor in #SolidTumors.
🌍 Now recruiting in #Australia with #US expansion soon!

👉 Read more https://buff.ly/3Dc92qj

#Onclogy #vc